2nd Quarter - Report

T1INTERNATIONAL USA for T1INTERNATIONAL USA

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the following bills: oAffordable Drug Manufacturing Act (no bill number yet) - To establish an Office of Drug Manufacturing within HHS and for them to manufacture generic drugs that the federal government has licensed. oS.4189: INSULIN Act - To reduce the price of insulin and provide for patient protections with respect to the cost of insulin. oH.R.3269/S.2276: ETHIC Act - would curb the practice of patent thicketing, bringing competition to the domestic biosimilars market and increasing access to lower cost treatments and cures.

LobbyistCovered position, as disclosed
SHAINA KASPER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2276 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.